Up to 72% of patients with prostate cancer who undergo radical prostatectomy experience urinary incontinence in the first 3 months after surgery. Up to 72% of patients experience urinary incontinence ...
The ARID II trial investigates the Voro Urologic Scaffold's safety and efficacy in prostate cancer patients undergoing robotic-assisted radical prostatectomy. The scaffold aims to improve urinary ...
SAN DIEGO, Oct. 6, 2006 (PRIMEZONE) -- As Prostate Cancer Awareness month came to a close last week, patients and members of the medical field were provided the latest information about the diagnosis, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results